WSJ
19 Aug 2026, 01:00 UTC · 4h ago
Big Food Is Fighting to Tempt Taste Buds in the Era of Weight-Loss Drugs
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
WSJ
19 Aug 2026, 01:00 UTC · 4h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
GLP-1 weight-loss drugs are threatening billions of dollars in sales for packaged-food manufacturers. — A structural decline in consumption volume directly threatens the top-line revenue and long-term growth projections of the packaged-food sector.
-0.80Packaged-food companies are developing new product strategies to attract and retain consumers using GLP-1 medications. — Proactive product adaptation suggests a potential mitigation strategy to offset volume losses, though efficacy remains unproven.
+0.30Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Continue reading
6 related stories
Search tags
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
Reuters
1d ago
